Search
for

    Sort by

    Research 61–90 of 1000+

    1. Administration of Caesalpinia bonduc Seed Extracts Ameliorates Testosterone-Induced Benign Prostatic Hyperplasia (BPH) in Male Wistar Rats Research and reports in urology · 2022 · 6 citations
    2. Inhibitory effects of TripTripterygium wilfordii multiglycoside on benign prostatic hyperplasia in rats 2015 · 5 citations
    3. Hepatoprotective and anti-hyperplastic effects of silver nanoparticles biosynthesised using aqueous extracts of <i>M. scaber</i> : Insights from acetaminophen and testosterone experimental models E3S Web of Conferences · 2026
    4. 5α-reductase Inhibitors: Finasteride and Dutasteride in Feminising Therapy Zenodo (CERN European Organization for Nuclear Research) · 2026 · 6 citations
    5. Finasteride in the treatment of Taiwanese men with androgenetic alopecia: a 12-month open-label study. PubMed · 2002 · 1 citations
    6. Hepatoprotective and anti-hyperplastic effects of silver nanoparticles biosynthesised using aqueous extracts of Springer Link (Chiba Institute of Technology) · 2026
    7. Oral Testosterone With and Without Concomitant Inhibition of 5α-Reductase by Dutasteride in Hypogonadal Men for 28 Days The Journal of Urology · 2010 · 11 citations
    8. 5α‐Reductase Inhibitors Andrology · 1997 · 17 citations
    9. Emerging medication for the treatment of male hypogonadism Expert Opinion on Emerging Drugs · 2012 · 77 citations
    10. Do 5α-Reductase Inhibitors Raise Circulating Serum Testosterone Levels? A Comprehensive Review and Meta-Analysis to Explaining Paradoxical Results Sexual Medicine Reviews · 2018 · 5 citations
    11. Genome-wide association study identifies a new locus JMJD1C at 10q21 that may influence serum androgen levels in men 2012 · 78 citations
    12. Higher Levels of Serum Uric Acid Have a Significant Association with Lower Incidence of Lower Urinary Tract Symptoms in Healthy Korean Men Metabolites · 2022 · 8 citations
    13. Efficacy of <i>Serenoa repens</i> lipido-sterolic extract alone or in combination with propolis polyphenols and <i>Boswellia serrata</i> extract suppositories on PSA level and symptoms in patients affected by lower urinary tract disorders Archivio Italiano di Urologia e Andrologia · 2025 · 1 citations
    14. Assessment of the usefulness of dihydrotestosterone in the diagnostics of patients with androgenetic alopecia Postepy Dermatologii I Alergologii · 2014 · 35 citations
    15. 5-Alpha-Reductase Inhibitors and Combination Therapy Urologic Clinics of North America · 2016 · 15 citations
    16. Total prostate volume as risk factor for semen pathologies in ageing male Journal of Men's Health · 2010
    17. Circulating and intraprostatic sex steroid hormonal profiles in relation to male pattern baldness and chest hair density among men diagnosed with localized prostate cancers The Prostate · 2017 · 7 citations
    18. THERAPEUTIC HOTLINE: Treatment of androgenic alopecia with finasteride may result in a high grade prostate cancer in patients: fact or fiction? Dermatologic Therapy · 2010 · 9 citations
    19. Effect of finasteride on prostate-specific antigen Lancet Oncology · 2006 · 2 citations
    20. The evolutionary impact of androgen levels on prostate cancer in a multi-scale mathematical model Biology direct · 2010 · 50 citations
    21. Relationship of Early-Onset Baldness to Prostate Cancer in African-American Men Cancer Epidemiology, Biomarkers & Prevention · 2013 · 21 citations
    22. The Optimal Indication for Testosterone Replacement Therapy in Late Onset Hypogonadism Journal of Clinical Medicine · 2019 · 17 citations
    23. Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia Frontiers in Pharmacology · 2020 · 35 citations
    24. Clinical Pearls in Men's Health Mayo Clinic Proceedings · 2010 · 1 citations
    25. The role of dutasteride in the treatment of benign prostatic obstruction and related conditions Aging Health · 2006
    26. Prevalence of metabolic syndrome and its components among men with and without clinical benign prostatic hyperplasia: a large, cross-sectional, UK epidemiological study BJUI · 2015 · 31 citations
    27. Re: Androgenetic Alopecia as an Early Marker of Benign Prostatic Hyperplasia The Journal of Urology · 2012 · 5 citations
    28. Doxazosin and finasteride alone or in combination: the PREDICT study BJUI · 2003 · 3 citations
    29. Estimating the Effect of Finasteride on Kallikrein Marker Levels in Blood and the Use of Converted Markers in the Four-Kallikrein Model European Urology Focus · 2026
    30. Endocrinology Clinical Chemistry and Laboratory Medicine · 2023